These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30170304)

  • 1. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial.
    Rezaei S; Akhlaghi M; Sasani MR; Barati Boldaji R
    Nutrition; 2019 Jan; 57():154-161. PubMed ID: 30170304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
    Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
    Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women with Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial.
    Atefi M; Entezari MH; Vahedi H; Hassanzadeh A
    Int J Clin Pract; 2022; 2022():4982080. PubMed ID: 35685535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flaxseed oil in the context of a weight loss programme ameliorates fatty liver grade in patients with non-alcoholic fatty liver disease: a randomised double-blind controlled trial.
    Rezaei S; Sasani MR; Akhlaghi M; Kohanmoo A
    Br J Nutr; 2020 May; 123(9):994-1002. PubMed ID: 31992372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH
    Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.
    Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Azadbakht L
    Nutrition; 2014; 30(7-8):814-21. PubMed ID: 24984998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial.
    Vahedi H; Atefi M; Entezari MH; Hassanzadeh A
    Trials; 2022 Jul; 23(1):551. PubMed ID: 35804451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olive Oil, Palm Oil, and Hybrid Palm Oil Distinctly Modulate Liver Transcriptome and Induce NAFLD in Mice Fed a High-Fat Diet.
    Sales RC; Medeiros PC; Spreafico F; de Velasco PC; Gonçalves FKA; Martín-Hernández R; Mantilla-Escalante DC; Gil-Zamorano J; Peres WAF; de Souza SAL; Dávalos A; Tavares do Carmo MG
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition of human VLDL triacylglycerols after ingestion of olive oil and high oleic sunflower oil.
    Ruiz-Gutiérrez V; Morgado N; Prada JL; Pérez-Jiménez F; Muriana FJ
    J Nutr; 1998 Mar; 128(3):570-6. PubMed ID: 9482765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balance of unsaturated fatty acids is important to a cholesterol-lowering diet: comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors.
    Binkoski AE; Kris-Etherton PM; Wilson TA; Mountain ML; Nicolosi RJ
    J Am Diet Assoc; 2005 Jul; 105(7):1080-6. PubMed ID: 15983524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
    Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
    Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of canola and olive oils consumption compared to sunflower oil, on lipid profile and hepatic steatosis in women with polycystic ovarian syndrome: a randomized controlled trial.
    Yahay M; Heidari Z; Allameh Z; Amani R
    Lipids Health Dis; 2021 Jan; 20(1):7. PubMed ID: 33514384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver lipid composition and antioxidant enzyme activities of spontaneously hypertensive rats after ingestion of dietary fats (fish, olive and high-oleic sunflower oils).
    Ruiz-Gutiérrez V; Vázquez CM; Santa-Maria C
    Biosci Rep; 2001 Jun; 21(3):271-85. PubMed ID: 11892994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olive oil antioxidants and non-alcoholic fatty liver disease.
    Abenavoli L; Milanović M; Milić N; Luzza F; Giuffrè AM
    Expert Rev Gastroenterol Hepatol; 2019 Aug; 13(8):739-749. PubMed ID: 31215262
    [No Abstract]   [Full Text] [Related]  

  • 16. The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsamos G; Kalopitas G; Evripidou K; Vasdeki D; Koufakis T; Kanavas V; Antza C; Germanidis G; Chourdakis M
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Pataky Z; Genton L; Spahr L; Lazarevic V; Terraz S; Gaïa N; Rubbia-Brandt L; Golay A; Schrenzel J; Pichard C
    Dig Dis Sci; 2016 Sep; 61(9):2721-31. PubMed ID: 27142672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Chen S; Zhao X; Ran L; Wan J; Wang X; Qin Y; Shu F; Gao Y; Yuan L; Zhang Q; Mi M
    Dig Liver Dis; 2015 Mar; 47(3):226-32. PubMed ID: 25577300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance.
    Rajcic D; Brandt A; Jin CJ; Sánchez V; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I
    PLoS One; 2020; 15(9):e0237946. PubMed ID: 32881925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.